Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 vaccination and Atypical hemolytic uremic syndrome
Romy N. Bouwmeester, Esther M.G. Bormans, Caroline Duineveld, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
Wioleta M. Zelek, R. A. Harrison
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152393-152393
Open Access | Times Cited: 27
Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review
Eleonora Francesca Pattonieri, Marilena Gregorini, Maria Antonietta Grignano, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 1, pp. 14-14
Open Access
Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccine
Claudia Stöllberger, Kastriot Kastrati, Clemens Dejaco, et al.
Wiener klinische Wochenschrift (2023) Vol. 135, Iss. 15-16, pp. 436-440
Open Access | Times Cited: 8
End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report
Mohammed Tawhari, Moustafa S Alhamadh, Abdulrahman Yousef Alhabeeb, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 679-679
Open Access | Times Cited: 7
Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
Christof Aigner, Martina Gaggl, Sophie Schmidt, et al.
Kidney International Reports (2023) Vol. 8, Iss. 8, pp. 1506-1513
Open Access | Times Cited: 7
Atypical hemolytic‐uremic syndrome after COVID‐19 vaccine: A case report
Marcos Adriano Garcia Campos, Rômullo José Costa Ataídes, Maxwell Cabral Ferreira, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 7
Open Access | Times Cited: 2
Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination–Associated Thrombotic Microangiopathy
Pujan Moradiya, Priyanka Khandelwal, Rupesh Raina, et al.
Kidney International Reports (2024) Vol. 9, Iss. 11, pp. 3134-3144
Open Access | Times Cited: 2
New‐onset and relapsed thrombotic microangiopathy post‐COVID‐19 vaccination
Qiqi Ma, Gaosi Xu
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 4
End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision
Veronica Moronti, Francesco Carubbi, Laura Sollima, et al.
Medicine (2023) Vol. 102, Iss. 50, pp. e36560-e36560
Open Access | Times Cited: 4
Atypical hemolytic uremic syndrome in a patient with HIV treated with eculizumab: A case report
Danilo E. Trujillo González, Dagoberto Duarte Misol, Nicolás Ariza Ordoñez, et al.
IDCases (2023) Vol. 31, pp. e01692-e01692
Open Access | Times Cited: 2
Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome
Vamsidhar Veeranki, Jeyakumar Meyyappan, Arpit Srivastava, et al.
Indian Journal of Nephrology (2024), pp. 1-8
Open Access
Eculizumab discontinuation in a patient with atypical hemolytic uremic syndrome after ChAdOx1 nCoV-19 vaccination
Marisa Roldão, Francisco Ferrer, Karina Lopes
Clinical Nephrology - Case Studies (2023) Vol. 11, Iss. 1, pp. 114-116
Open Access | Times Cited: 1
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan
I−Ru Chen, Guei‐Jane Wang, Po‐Ren Hsueh, et al.
Vaccine (2023) Vol. 41, Iss. 41, pp. 5940-5945
Closed Access | Times Cited: 1
AZD-1222/tozinameran

Reactions Weekly (2023) Vol. 1942, Iss. 1, pp. 68-68
Closed Access
A Rare and Complex Case of Multifactorial Thrombotic Microangiopathy in A Kidney Transplant Recipient: Interplay Between Antibody Mediated Rejection, Tacrolimus Toxicity, Cytomegalovirus Disease and BNT162b2mRNA Vaccine
Paayal Naidu, William Majoni, Toby Coates, et al.
OBM Transplantation (2023) Vol. 07, Iss. 03, pp. 1-13
Open Access
Page 1

Scroll to top